Key result
Metoprolol and verapamil manage dynamic LVOT obstruction in concurrent apical HCM and subaortic membrane.
Why the study?
The coexistence of hypertrophic obstructive cardiomyopathy and subaortic membrane presents complex diagnostic challenges.
Case Report (n=1)
This case highlights the diagnostic complexity and individualized medical management required for the rare coexistence of apical hypertrophic cardiomyopathy and a subaortic membrane.
Supports medical management with metoprolol and verapamil in this overlap; leaves open optimal strategy pending larger studies.
Hypertrophic obstructive cardiomyopathy (HOCM) and subaortic membrane (SAS) are distinct cardiac conditions, but their coexistence presents complex diagnostic challenges. We report the case of a 52-year-old male with HOCM and a concurrent subaortic membrane, highlighting the intricacies of diagnosis and management. The patient's presentation included symptoms of dyspnea and chest tightness, and diagnostic evaluations revealed a unique combination of dynamic left ventricular outflow tract (LVOT) obstruction from HOCM and fixed obstruction from the subaortic membrane. This case emphasizes the importance of a comprehensive diagnostic workup to guide appropriate treatment decisions when managing multiple cardiac abnormalities.
No takes yet. Share an insight, caveat, or question.
Hussain et al. (2024) conducted a case report in Apical Hypertrophic Cardiomyopathy with Sub-aortic Membrane (n=1). Medical management (metoprolol and verapamil) was evaluated. A 52-year-old male with concurrent apical hypertrophic cardiomyopathy and a subaortic membrane was successfully managed with metoprolol and verapamil to address symptoms and dynamic LVOT obstruction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: